Assessment of the control measures for category A diseases of Animal Health Law: Contagious Bovine Pleuropneumonia.

Contagious Bovine Pleuropneumonia Disease control measures Mycoplasma mycoides subsp. mycoides monitoring period protection zone sampling procedures surveillance zone

Journal

EFSA journal. European Food Safety Authority
ISSN: 1831-4732
Titre abrégé: EFSA J
Pays: United States
ID NLM: 101642076

Informations de publication

Date de publication:
Jan 2022
Historique:
entrez: 26 1 2022
pubmed: 27 1 2022
medline: 27 1 2022
Statut: epublish

Résumé

EFSA received a mandate from the European Commission to assess the effectiveness of some of the control measures against diseases included in the Category A list according to Regulation (EU) 2016/429 on transmissible animal diseases ('Animal Health Law'). This opinion belongs to a series of opinions where these control measures will be assessed, with this opinion covering the assessment of control measures for Contagious Bovine Pleuropneumonia (CBPP). In this opinion, EFSA and the AHAW Panel of experts review the effectiveness of: (i) clinical and laboratory sampling procedures, (ii) monitoring period, (iii) the minimum radius of the protection and surveillance zones, and (iv) the minimum length of time the measures should be applied in these zones. The general methodology used for this series of opinions has been published elsewhere. Several scenarios for which these control measures had to be assessed were designed and agreed prior to the start of the assessment. Different clinical and laboratory sampling procedures are proposed depending on the scenarios considered. The monitoring period of 45 days was assessed as not effective and at least 90 days (3 months) is recommended in affected areas where high awareness is expected; when the index case occurs in an area where the awareness is low the monitoring period should be at least 180 days (6 months). Since transmission kernels do not exist and data to estimate transmission kernels are not available, the effectiveness of surveillance and protection zones for CBPP was based on expert knowledge. A surveillance zone of 3 km was considered effective, while a protection zone including establishments adjacent to affected ones is recommended. Recommendations, provided for each of the scenarios assessed, aim to support the European Commission in the drafting of further pieces of legislation, as well as for plausible ad hoc requests in relation to CBPP.

Identifiants

pubmed: 35079288
doi: 10.2903/j.efsa.2022.7067
pii: EFS27067
pmc: PMC8777562
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e07067

Informations de copyright

© 2022 Wiley‐VCH Verlag GmbH & Co. KgaA on behalf of the European Food Safety Authority.

Références

EFSA J. 2022 Jan 21;20(1):e07067
pubmed: 35079288
Mol Cell Probes. 1997 Apr;11(2):103-11
pubmed: 9160324
Vet J. 2012 Feb;191(2):166-70
pubmed: 21439870
Rev Sci Tech. 1996 Dec;15(4):1309-29
pubmed: 9190018
Vet Res. 1999 Sep-Oct;30(5):457-66
pubmed: 10543380
Onderstepoort J Vet Res. 2007 Sep;74(3):251-63
pubmed: 17933367
Vet Res. 2006 Sep-Oct;37(5):733-44
pubmed: 16820137
Prev Vet Med. 2011 Aug 1;101(1-2):89-95
pubmed: 21620492
Bull Epizoot Dis Afr. 1970 Sep;18(3):201-5
pubmed: 4945496
Trop Biomed. 2020 Jun 1;37(2):273-281
pubmed: 33612797
EFSA J. 2017 Oct 04;15(10):e04995
pubmed: 32625292
EFSA J. 2018 Jan 24;16(1):e05123
pubmed: 32625671
Vet Microbiol. 1998 Feb 28;60(2-4):179-91
pubmed: 9646449
J Vet Diagn Invest. 1994 Oct;6(4):428-34
pubmed: 7858022
Res Vet Sci. 2012 Oct;93(2):568-73
pubmed: 21963291
Vet Rec. 1995 Jan 28;136(4):98-9
pubmed: 7740725
Rev Sci Tech. 2000 Dec;19(3):764-72
pubmed: 11107619
J Biotechnol. 2016 Oct 20;236:35-44
pubmed: 27497759
Vet Microbiol. 1994 Dec;42(4):327-39
pubmed: 9133058
J Vet Med B Infect Dis Vet Public Health. 2003 Aug;50(6):298-303
pubmed: 14629002
BMC Vet Res. 2011 Aug 12;7:47
pubmed: 21838878
PLoS One. 2012;7(10):e46821
pubmed: 23071648
Vet Q. 1992;14(3):104-10
pubmed: 1413440
J Hyg (Lond). 1986 Oct;97(2):305-15
pubmed: 3782785
Microbiology (Reading). 1995 Dec;141 ( Pt 12):3221-8
pubmed: 8574413
Vet Immunol Immunopathol. 2016 Oct 1;178:64-9
pubmed: 27496744
Vet Pathol. 2020 Jul;57(4):476-489
pubmed: 32390522
Vaccine. 1986 Dec;4(4):266-70
pubmed: 3799020
Ann N Y Acad Sci. 2000;916:71-80
pubmed: 11193704
Trop Anim Health Prod. 2013 Mar;45(3):699-703
pubmed: 23334379
Vet Immunol Immunopathol. 2016 Mar;171:103-14
pubmed: 26964722
Heliyon. 2020 Oct 08;6(10):e05146
pubmed: 33083610
Mol Cell Probes. 2008 Oct-Dec;22(5-6):324-8
pubmed: 18678244
Trop Anim Health Prod. 2015 Feb;47(2):395-402
pubmed: 25433650

Auteurs

Classifications MeSH